Please login to the form below

Not currently logged in
Email:
Password:

Rock Unlimited appoints Ben Fisher as its director

Joins Terry Bradley and Clare Peck on the Rock Unlimited board

Ben Fisher RockBen Fisher has been appointed as med comms agency Rock Unlimited's new director. 

Fisher brings with him an innovative approach to scientific engagement and 13 years' experience within healthcare communications. 

He has held senior roles across Omnicom (Porter Novelli) and WPP (Ogilvy Healthworld) and more recently a stint at the Hive Group.

Terry Bradley, managing director at Rock Unlimited, said: “Ben is the ideal person to join the growing team. He brings a passion for healthcare communication, great enthusiasm for his work and a first class client service ethic.” 

Fisher has been involved in many educational programmes including disease awareness, message development, educational games, patient support programmes, product launches and digital platforms.

Catherine Warne, CEO of Health Unlimited, said: “The Health Unlimited mission is to connect healthcare brands with their key stakeholders through a bespoke team of specialists.  Ben's multi-disciplinary approach ensures scientific rigor is aligned with intelligent innovation leading to creative and insightful campaigns.”

Ben joins Terry Bradley and Clare Peck on the Rock Unlimited board. 

15th June 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics